Market Cap (In USD)
17.98 Billion
Revenue (In USD)
1.69 Billion
Net Income (In USD)
206.3 Million
Avg. Volume
731.32 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 160.19-279.77
- PE
- -
- EPS
- -
- Beta Value
- 1.219
- ISIN
- US45784P1012
- CUSIP
- 45784P101
- CIK
- 1145197
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dr. James R. Hollingshead Ph.D.
- Employee Count
- -
- Website
- https://www.insulet.com
- Ipo Date
- 2007-05-15
- Details
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
More Stocks
-
FINCABLESFinolex Cables Limited
FINCABLES
-
7CDCD Projekt SA
7CD
-
PRPI
-
MFSINTRCRPMFS Intercorp Limited
MFSINTRCRP
-
IDEXY
-
CPLComperia.pl S.A.
CPL
-
ESABINDIAESAB India Limited
ESABINDIA
-
0JZUMcKesson Corporation
0JZU